欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2022, Vol. 27 ›› Issue (8): 892-898.doi: 10.12092/j.issn.1009-2501.2022.08.008

• 综述与讲座 • 上一篇    下一篇

基于衰老视角评析肌少症实验药理模型的研究进展

付勇芳1,郭怡洵1,王晶2,李文雄3,张岩1,4   

  1. 1上海中医药大学附属龙华医院,上海 200032;2上海市中医老年医学研究所,上海 200031;
    3陕西中医药大学附属医院,咸阳 712046,陕西;4教育部筋骨理论与治法重点实验室,上海 200032
  • 收稿日期:2022-04-21 修回日期:2022-07-04 出版日期:2022-08-26 发布日期:2022-09-13
  • 通讯作者: 张岩,男,博士,研究员,博士生导师,研究方向:代谢性疾病与药理学。 Tel: 021-64385700 E-mail: medicineyan@aliyun.com
  • 作者简介:付勇芳,女,硕士研究生,研究方向:代谢性疾病与药理学。 E-mail: fuyongfang24@163.com 郭怡洵,共同第一作者,女,硕士研究生,研究方向:代谢性疾病与药理学。 E-mail: gyx9818@163.com
  • 基金资助:
    国家自然科学基金(82074468);上海市科技创新行动计划(21400760400);上海市优秀学术带头人计划(19XD1423800)

Research progress on experimental pharmacology models of sarcopenia from the view of senescence

FU Yongfang1, GUO Yixun1, WANG Jing2, LI Wenxiong3, ZHANG Yan1,4   

  1. 1Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China; 2Shanghai Geriatric Institute of Chinese Medicine, Shanghai 200031, China; 3Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China; 4Key Laboratory of Theory and Therapy of Muscles and Bones, Ministry of Education, Shanghai 200032, China
  • Received:2022-04-21 Revised:2022-07-04 Online:2022-08-26 Published:2022-09-13

摘要: 肌少症主要表现为骨骼肌质量、力量和功能的进行性下降,已经成为老年肌肉骨骼系统的主要慢性疾病之一。在基础研究中,可靠的实验模型对于深入理解肌少症的病理生理机制以及新药研发具有重要意义。本文初步总结了衰老诱导肌少症的潜在机制,并重点从体外细胞模型、体内动物模型,讨论基于衰老分子机制的肌少症药理模型的研究进展。

关键词: 肌少症, 衰老, 药理模型, 骨骼肌

Abstract: Sarcopenia, characterized as the progressive decrease in skeletal muscle mass, strength, and function, has been becoming one of chronic musculoskeletal diseases in aging people. In basic research studies, a reliable experimental model would be vital significance for deeply understanding pathophysiological mechanism of sarcopenia and developing novel drugs. This review provided a preliminary summary on the potential mechanisms involved in senescence-induced sarcopenia, followed by a discussion on research progress on pharmacology models based on molecular mechanism of senescence, especially from in vitro cell models and in vivo animal models.

Key words: sarcopenia, senescence, pharmacological model, skeletal muscle

中图分类号: